Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple breathing and walking exercises may speed lung recovery after COVID-19 pneumonia

NCT ID NCT07656610

Disease control Sponsor: Hitit University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates whether respiratory muscle training and walking exercises can improve lung function, reduce breathlessness, and enhance quality of life in women who have recovered from COVID-19 pneumonia. Eighty women aged 20 to 45 are divided into four groups: a combination of breathing and walking exercises, breathing exercises alone, walking alone, or no exercise. Researchers measure changes in breathing strength, lung capacity, exercise ability, and symptoms over eight weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
respiratory muscle training and walking exercise
What this could lead to
If effective, these simple exercises could become a standard part of recovery programs for people with lingering breathing problems after COVID-19 pneumonia.
What could go wrong
This is a small, early-stage study with only 80 women, so results may not apply to everyone. The exercises may not lead to meaningful improvements in lung function or quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Jan 2023

Finished

May 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female participants aged 20 to 45 years * History of COVID-19-related pneumonia * Presence of dyspnea after COVID-19 * Modified Borg dyspnea score between 1 and 7 after the 6-minute walk test * Resting oxygen saturation between 90% and 95% * Incomplete resolution of COVID-19-related lesions on chest radiography * Voluntary agreement to participate in the study * Signed written informed consent form Exclusion Criteria: * Modified Borg dyspnea score between 0 and 1 * Modified Borg dyspnea score greater than 7 * History of chronic obstructive pulmonary disease, heart failure, or pulmonary fibrosis causing dyspnea before COVID-19 pneumonia * Upper abdominal or thoracic surgery within the previous 3 months * Cancer * Pregnancy * Presence of another disease contributing to dyspnea in addition to COVID-19-related dyspnea * Cardiovascular, musculoskeletal, or nervous system involvement related to COVID-19 * Mental disorder or mental instability * Language barrier preventing understanding of Turkish * Refusal to participate or withdrawal from the study at any stage * History of being a competitive athlete * Lack of voluntary participation or refusal to sign the written informed consent form

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 pneumonia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

COVID-19 Dyspnea Signs and Symptoms, Respiratory

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19 pneumonia Respiratory symptoms

Contacts and locations

Locations

  • Hitit University Çorum Erol Olçok Training and Research Hospital

    Çorum, Çorum, 19100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.